Insider Holders & Insider Ownership - Neurogene Inc. (NGNE)

List of insiders holdings for Neurogene Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
BAKER BROS. ADVISORS LP
667 L.P.
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
Former 10% Owner
Director
2023-12-20 18:43:06226
7,831,540
7,831,766Form 4
Redmile Group LLC
Green Jeremy
10% Owner
2024-02-14 16:26:221,050,304
0
1,050,304Form 13G
Ventures West 8 Limited Partnership
10% Owner
2016-02-16 15:21:101,020,430
0
1,020,430Form 13G
PFIZER INC
10% Owner
2015-08-18 17:05:42481,529
0
481,529Form 13G
Main David
President and CEO
2018-08-09 19:07:07415,000
0
415,000Form 4
DRACHMAN JONATHAN G
President and CEO
2022-08-04 16:38:51350,000
0
350,000Form 4
Alam Kamran
CFO, Vice President Finance
2018-08-09 19:03:08195,000
0
195,000Form 4
Walkey Carl
Senior Vice President
2022-08-04 16:43:37150,000
0
150,000Form 4
MacKenzie Lloyd
Chief Operating Officer
2018-08-09 19:04:32145,000
0
145,000Form 4
Cvijic Christine Mikail
President and CFO
2024-03-14 20:53:21106,744
0
106,744Form 4
Cochener Donna
General Counsel, SVP Legal
2022-08-04 16:37:38100,000
0
100,000Form 4
Vance Holly
General Counsel
2021-08-05 16:25:06100,000
0
100,000Form 4
McMinn Rachel
Chief Executive Officer
2024-03-14 20:54:5593,282
0
93,282Form 4
Troupin Barbara
Chief Medical Officer
2018-03-13 17:04:3175,000
0
75,000Form 4
McCloskey Shelley
VP, HR and Administration
2018-08-09 19:05:3775,000
0
75,000Form 4
Jenkins Abigail
Chief Commercial Officer
2018-03-13 16:53:3275,000
0
75,000Form 4
Jordan Julie
Chief Medical Officer
2024-01-18 18:48:2075,000
0
75,000Form 4
Ho Robert
Chief Financial Officer
2022-02-02 16:36:5970,000
0
70,000Form 4
Cobb Stuart
Chief Scientific Officer
2024-03-14 20:51:4354,841
0
54,841Form 4
Patel Priti
Former Chief Medical Officer
2023-04-04 20:51:0337,313
0
37,313Form 4
SHREWSBURY STEPHEN B
CMO; Senior VP Clinical Dev.
2016-03-14 17:42:1135,000
0
35,000Form 4
Lavelle Erin
Director
2023-06-09 16:25:3225,000
0
25,000Form 4
SIMPSON TODD E
Director
2023-06-09 16:28:1825,000
0
25,000Form 4
Babler Martin
Director
2023-06-09 16:24:4125,000
0
25,000Form 4
Williams Lewis T
Director
2021-05-13 17:39:2625,000
0
25,000Form 4
Lavelle Erin M.
Director
2021-05-13 17:37:1325,000
0
25,000Form 4
Nolan Sean P.
Director
2020-05-07 16:25:3325,000
0
25,000Form 4
Mitchell David Chilton
VP Global Regulatory & Quality
2017-03-10 21:20:0725,000
0
25,000Form 4
Smith Sean Michael
Interim CFO, Prin Acct Off
2023-08-14 16:06:5521,637
0
21,637Form 4
Pelzer Robert
Director
2018-05-09 18:17:3715,000
0
15,000Form 4
Bridger Gary
Director
2018-05-09 18:15:5915,000
0
15,000Form 4
Woods Robert Keith
Director
2024-06-17 14:37:337,700
0
7,700Form 4
PALEKAR ROHAN
Director
2024-06-17 14:37:017,700
0
7,700Form 4
BAFFI ROBERT
Director
2024-06-17 14:36:287,700
0
7,700Form 4
Noonberg Sarah B.
Director
2024-06-17 14:36:037,700
0
7,700Form 4
Freedland Cory S.
Director
2024-06-17 14:35:377,700
0
7,700Form 4
Neu Kelvin
Director
2017-03-27 18:07:3236
0
36Form 3
JOHNSON & JOHNSON
Johnson & Johnson Innovation - JJDC Inc.
10% Owner
2016-02-12 15:19:260
0
0Form 13G
Levy Richard S
Director
2017-03-27 17:04:420
0
0Form 3
LEVITT DANIEL J
Director
2018-05-16 19:45:260
0
0Form 4
Boyd Meta Cantey
Director
2019-08-23 15:58:290
0
0Form 3
Jones Elaine V
Director
2014-03-06 17:25:340
0
0Form 3